 CELEBRATION, Fla., June 16, 2021 GLOBE NEWSWIRE -- KemPharm, Inc. NASDAQ: KMPH, a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that Travis C. Mickle, Ph.D., President and CEO of KemPharm, has issued a Letter to Shareholders in connection with the Companys 2021 Annual Meeting of Stockholders to be held on June 17, 2021. The letter provides an update on recent events and outlook for the remainder of 2021 and early 2022. 